Bristol-Myers Squibb's total assets for Q2 2026 were $87.63B, an increase of 1.34% from the previous quarter. MX:BMY total liabilities were $65.31B for the fiscal quarter, a -1.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.